NY-AG v. Purdue Pharma

Purdue Pharma allegedly engaged in a decades-long and continuing pattern of persistent deceptive and conduct. According to NY-AG, Purdue misled prescribers and patients about the risks of its opioids, including OxyContin, intentionally understating the risks and overstating the benefits of these powerful and dangerous drugs. Purdue allegedly concealed the link between long-term use of opioids and abuse and addiction, masking the signs of addiction by referring to them as “pseudoaddiction,” falsely claiming that withdrawal from its products can be easily managed, overstating the risks of alternative pain relief therapies as compared to opioids, and misrepresenting the extent to which opioids improve body function.

Summary generated from official New York Attorney General press release